Logo
x

Search

Subscribe Now

inventisbio

InventisBio Reports Results from the P-II Trial of D-2570 to Treat Moderate to Severe Plaque Psoriasis

InventisBio Reports Results from the P-II Trial of D-2570 to Treat Moderate to Severe Plaque Psoriasis

  • December 3, 2024
Betta Pharma Licenses Inventisbio's D-0316 to Treat Non-Small Cell Lung Cancer (NSCLC)

Betta Pharma Licenses Inventisbio's D-0316 to Treat Non-Small Cell Lung Cancer (NSCLC)

  • December 31, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.